S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Innocan Pharma Expands VALITIC Skincare Beyond Amazon With New DTC Site

Innocan Pharma is moving to diversify its retail footprint, launching a dedicated direct-to-consumer website for its VALITIC skincare line. The move marks a strategic shift for the brand, which has previously relied on Amazon to build its U.S. presence, ahead of a planned marketing push for the 2026 holiday season.

Innocan Pharma Expands VALITIC Skincare Beyond Amazon With New DTC Site
Photo: Bio & News

The new portal, ValiticBeauty.com, allows the company to establish a closer relationship with its customer base while gathering data to refine the shopping experience. By moving away from a single-channel dependency, the brand aims to establish a more scalable multi-channel business model. Roni Kamhi, CEO of B.I. Sky Global, noted that the current phase is focused on platform optimization to ensure a smooth transition into the high-volume holiday period.

Iris Bincovich, CEO of parent company Innocan Pharma, emphasized that the dual-channel approach—balancing Amazon’s reach with the autonomy of a proprietary site—provides a sturdier foundation for growth. The company, which operates through its 60%-owned subsidiary B.I. Sky Global, plans to leverage this expanded distribution to capture a larger share of the competitive U.S. personal care market.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!